US8187266B2 - Surgical probe and methods for targeted treatment of heart structures - Google Patents

Surgical probe and methods for targeted treatment of heart structures Download PDF

Info

Publication number
US8187266B2
US8187266B2 US11537561 US53756106A US8187266B2 US 8187266 B2 US8187266 B2 US 8187266B2 US 11537561 US11537561 US 11537561 US 53756106 A US53756106 A US 53756106A US 8187266 B2 US8187266 B2 US 8187266B2
Authority
US
Grant status
Grant
Patent type
Prior art keywords
energy
delivering
member
method
heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related, expires
Application number
US11537561
Other versions
US20080082099A1 (en )
Inventor
Duane Dickens
Thomas Witzel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VALVECURE Inc
Original Assignee
QuantumCor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • A61B2018/00797Temperature measured by multiple temperature sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • A61B2018/00821Temperature measured by a thermocouple
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1405Electrodes having a specific shape
    • A61B2018/1407Loop
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1475Electrodes retractable in or deployable from a housing

Abstract

A surgical probe and methods for targeted treatment of structures of the heart with heat and radiofrequency energy. The probe which is designed to operated by hand has a elongate member with a handle and an energy-delivering member in an adjustable loop configuration. The control placed on the handle allow the user to alter the length of the loop configuration of the energy-delivering member and to thus place energy-delivering elements located on the energy-delivering member at selected or targeted portions of the heart or structures within the heart. The elongate member is conformable and can be bent into different configurations to allow additional targeted treatment of the particular portions of the heart.

Description

BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention generally relates to a surgical probe for treating and repairing heart structures and more particularly, relates to a surgical probe for treating and repairing tissues and anatomic structures within the heart with heat and radiofrequency energy.

2. Description of the Related Art

It is estimated over twelve million people around the world suffer from Congestive Heart Failure (CHF). CHF is a family of related conditions defined by the failure of the heart to pump blood efficiently resulting in congestion (or backing up of the blood) in the lungs or peripheral circulation. CHF can ultimately lead to end-organ failure, which contributes to death of the patient. The heart muscle of the CHF patient may be altered with the chambers dilated and the heart walls thickened or thinned. CHF can result from several conditions, including infections of the heart muscle or valve, physical damage to the valve or by damaged muscle caused by infarction (heart attack).

CHF is the fastest growing cardiovascular disease with over 1 million new cases occurring each year. Conservative estimates suggest that the prevalence of CHF will more than double by 2007. If untreated, CHF may result in severe lifestyle restrictions and ultimately death. One of the causes of CHF and a very common contributor to the harmful effects of CHF is a leaky mitral heart valve. The mitral valve is located in the center of the heart between the two left or major heart chambers and plays an important role in maintaining forward flow of blood. The medical term for this leaky condition is “mitral regurgitation” and the condition affects well over one million people globally. Mitral regurgitation is also called ‘mitral incompetence’ or ‘mitral insufficiency’.

For general background information, the circulatory system consists of a heart and blood vessels. In its path through the heart, the blood encounters four valves. The valve on the right side that separates the right atrium from the right ventricle has three cusps and is called the tricuspid valve. It closes when the ventricle contracts during a phase known as systole and it opens when the ventricle relaxes, a phase known as diastole.

The pulmonary valve separates the right ventricle from the pulmonary artery. It opens during systole, to allow the blood to be pumped toward the lungs, and it closes during diastole to keep the blood from leaking back into the heart from the pulmonary artery. The pulmonary valve has three cusps, each one resembling a crescent and it is also known as a semi-lunar valve.

The two-cusped mitral valve, so named because of its resemblance to a bishop's mitre, is in the left ventricle and it separates the left atrium from the ventricle. It opens during diastole to allow the blood stored in the atrium to pour into the ventricle, and it closes during systole to prevent blood from leaking back into the atrium. The mitral valve and the tricuspid valve differ significantly in anatomy. The annulus of the mitral valve is somewhat D-shaped whereas the annulus of the tricuspid valve is more nearly circular.

The fourth valve is the aortic valve. It separates the left ventricle from the aorta. It has three semi-lunar cusps and it closely resembles the pulmonary valve. The aortic valve opens during systole allowing a stream of blood to enter the aorta and it closes during diastole to prevent any of the blood from leaking back into the left ventricle. In a venous circulatory system, a venous valve functions to prevent the venous blood from leaking back into the upstream side so that the venous blood can return to the heart and the lungs for blood oxygenating purposes.

Clinical experience has shown that repair of a valve, either a heart valve or a venous valve, produces better long-term results than does valve replacement. Valve replacement using a tissue valve suffers long-term calcification problems. On the other hand, anticoagulation medicine, such as cumadin, is required for the life of a patient when a mechanical valve is used in valve replacement. The current technology for valve repair or valve replacement requires an expensive open-heart surgery that needs a prolonged period of recovery. A less invasive repair technology presents an unmet clinical challenge.

The effects of valvular dysfunction vary. Mitral regurgitation may have more severe physiological consequences to the patient than does tricuspid valve regurgitation. In patients with valvular insufficiency, it is an increasingly common surgical practice to repair the natural valve, and to attempt to correct the defects. Many of the defects are associated with dilation of the valve annulus. This dilatation not only prevents competence of the valve but also results in distortion of the normal shape of the valve orifice or valve leaflets. Remodeling of the annulus is therefore central to most reconstructive procedures for the mitral valve.

As a part of the valve repair, it is desired to either diminish or constrict the involved segment of the annulus so that the leaflets may coapt correctly on closing, or to stabilize the annulus to prevent post operative dilatation from occurring. The current open-heart approach is by implantation of a prosthetic ring, such as a Cosgrove Ring or a Carpentier Ring, in the supra annular position. The purpose of the ring is to restrict and/or support the annulus to correct and/or prevent valvular insufficiency. In tricuspid valve repair, constriction of the annulus usually takes place in the posterior leaflet segment and in a small portion of the adjacent anterior leaflet.

Various prostheses have been described for use in conjunction with mitral or tricuspid valve repair. The ring developed by Carpentier, U.S. Pat. No. 3,656,185, is rigid and flat. An open ring valve prosthesis as described in U.S. Pat. No. 4,164,046 comprises a uniquely shaped open ring valve prosthesis having a special velour exterior for effecting mitral and tricuspid annuloplasty. The fully flexible annuloplasty ring could only be shortened in the posterior segment by the placement of plicating sutures. U.S. Pat. No. 5,674,279 to Wright et al. discloses a suturing ring suitable for use on heart valve prosthetic devices for securing such devices in the heart or other annular tissue. All of the above valve repair or replacement requires an open-heart operation which is costly and exposes a patient to higher risk and longer recovery than a less invasive procedure.

Moderate heat is known to tighten and shrink the collagen tissue as illustrated in U.S. Pat. Nos. 5,456,662 and 5,546,954. It is also clinically verified that thermal energy is capable of denaturing the tissue and modulating the collagenous molecules in such a way that treated tissue becomes more resilient (See “The Next Wave in Minimally Invasive Surgery”, Medical Device & Diagnostic Industry, pp. 36-44, August 1998). Therefore, it becomes imperative to treat the inner walls of an annular organ structure of a heart valve, a valve leaflet, chordae tendinae, papillary muscles, and the like by shrinking/tightening techniques. The same shrinking/tightening techniques are also applicable to stabilize injected biomaterial to repair the defect annular organ structure, wherein the injectable biomaterial is suitable for penetration and heat initiated shrinking/tightening.

One method of reducing the size of tissues in situ has been used in the treatment of many diseases, or as an adjunct to surgical removal procedures. This method applies appropriate heat to the tissues, and causes them to shrink and tighten. It can be performed in a minimal invasive or percutaneous fashion, which is often less traumatic than surgical procedures and may be the only alternative method, wherein other procedures are unsafe or ineffective. Ablative treatment devices have an advantage because of the use of a therapeutic energy that is rapidly dissipated and reduced to a non-destructive level by conduction and convection, to other natural processes.

Radio frequency (RF) therapeutic protocol has been proven to be highly effective when used by electrophysiologists for the treatment of tachycardia, atrial flutter and atrial fibrillation. It has also been proven effective by neurosurgeons for the treatment of Parkinson's disease, by otolaryngologists for clearing airway obstruction and by neurosurgeons and anesthetists for other RF procedures such as Gasserian ganglionectomy for trigeminal neuralgia and percutaneous cervical cordotomy for intractable pains.

Radiofrequency treatment, which exposes a patient to minimal side effects and risks, is generally performed after first locating the tissue sites for treatment. Radiofrequency energy, when coupled with a temperature control mechanism, can be supplied precisely to the device to tissue contact site to obtain the desired temperature for treating a tissue or for effecting the desired shrinking of the host collagen or injected bioresorbable material adapted to immobilize the biomaterial in place.

U.S. Pat. No. 6,258,087 to Edwards et al. discloses an expandable electrode assembly comprising a support basket formed from an array of spines for forming lesions to treat dysfunction in sphincters. Electrodes carried by the spines are intended to penetrate the tissue region upon expansion of the basket. The assembly disclosed by Edwards et al. does not teach a probe that allows the user to target numerous portions of the heart for treatment while the probe is inserted within the patient.

U.S. Pat. No. 6,355,030 to Aldrich et al. discloses instruments and methods for treating and repairing heart valve structures. Aldrich et al. discloses an apparatus with a handle portion and a heating member in a ring-shaped annular configuration at the distal end of the handle portion. Both the handle portion and the heating member are made from a conformable material which are manipulated by a treating physician to shape the apparatus by hand to fit an individual patient geometries and particular clinical applications. The apparatus shown in Aldrich et al. does not teach that the heating member can be manipulated by a control to target different portions of the heart for treatment while the heating member is within the patient. If the Aldrich apparatus required manipulation by the treating physician, it would have to be first retracted from the patient, then reinserted followed by possible repeated retraction-reinsertion cycles, thus lengthening the surgical procedure and possibly endangering the patient.

Therefore, because of the above mentioned problems and limitations in conventional treatments and surgical devices, there is a need to have less invasive surgical probes and methods for treating structures of the heart including heart valves and for in situ targeted treatment of particular heart structures.

Background of the Invention

One or more embodiments of the invention are directed to surgical probes and methods for targeted treatment of heart structures and more particularly, for a surgical probe and methods that utilizes tissue-shrinkable energy for treating and repairing tissues surrounding anatomic structures within the heart.

In one embodiment, the surgical probe of the present invention is used for repairing an annular organ structure of a patient. The probe has an elongate member adapted to allow insertion of at least a portion of the member into a body vessel. At a distal end of the elongate member, there is an energy-delivering member with an adjustable length that extends from the distal end of the elongate member in an adjustable loop. Energy-delivering elements are operably connected to the energy-delivering member and are powered by energy sources well-known to persons skilled in the art.

A user-operated control is located at the proximal end of the elongate member to adjust the length of the energy delivering member. The energy-delivering elements are placed in communication with selected portions of the organ structure by the user-controlled length adjustments of the energy delivering member and thus the energy-delivering elements supply tissue-shrinkable energy to selected portions of the organ structure and are placed in communication with numerous portions without the need to withdraw the energy-delivering member to re-configure the member to conform to another organ structure. Thus, the same amount of treatment to specific targeted areas can be accomplished in less time.

In one embodiment, the elongate member is comprised of a malleable material to further allow the probe to conform to the anatomy of the heart structure undergoing treatment. In another embodiment, the energy-delivering elements are electrodes and in another embodiment the energy-delivering elements include a radiofrequency source. In an embodiment, the tissue-shrinkable energy is heat energy and in one embodiment the tissue shrinkable energy includes radiofrequency energy.

In one embodiment, the surgical probe has at least one thermocouple in communication with each of the electrodes while in another embodiment, the surgical probe has at least two thermocouples in communication with each of the electrodes.

In one embodiment, the invention includes a method for repairing an annular organ structure of a patient. In this embodiment, the method includes the steps of utilizing a surgical probe by placing at least a portion of the energy-delivering member within a body vessel, placing the energy-delivering elements in communication with selected portions of the organ structure by user-controlled length adjustments of the energy-delivering member through user input to the control and then supplying tissue-shrinkable energy to selected portions of the organ structure that are in communication with said energy-delivering elements.

In one embodiment, the method includes the step where the elongate member is made of a conformable material and configured to further place the energy-delivering elements in communication with the selected portions of the organ structure. The energy-delivering elements can include electrodes and a radiofrequency source.

Other and further objects and advantages will be apparent to persons skilled in the art from the figures and written disclosure including the claims herein.

BRIEF DESCRIPTION OF THE DRAWINGS

Additional objects and features of the present invention will become more apparent and the invention itself will be best understood from the following Detailed Description, when read with reference to the accompanying drawings.

FIG. 1 is one embodiment of a surgical probe of the present invention.

FIG. 2 is a side view of another embodiment of the invention illustrating a malleable elongate member.

FIG. 3 is a side view of one embodiment of the surgical probe of the present invention showing the additional length of the energy-delivering member.

FIG. 4 is a side view of an embodiment of the surgical probe of the present invention showing a withdrawal of the length of the energy-delivering member for positioning of the energy-delivering elements.

FIG. 5 is a side view of one embodiment showing additional retraction of the length of the energy-delivering member for further positioning of the energy-delivering elements.

DETAILED DESCRIPTION OF THE INVENTION

The following descriptions of the preferred embodiment of the invention are exemplary, rather than limiting, and many variations and modifications are within the scope and spirit of the invention. Although numerous specific details are set forth in order to provide a thorough understanding of the present invention, it will be apparent to one of ordinary skill in the art, that embodiments of the invention may be practiced without these specific details. In other instances, well-known features have not been described in detail in order to avoid unnecessarily obscuring the present invention limiting, and many variations and modifications are within the scope of the invention without all of the details or parts described herein.

One or more embodiments of the invention are directed to a surgical probe and methods for targeted treatment of heart structures. FIG. 1 shows an embodiment of the surgical probe 10 of the present invention that has an elongate member 12 with a proximal end 14 and distal end 16. A handle portion 18 is positioned at the proximal end 14 and configured to be grasped by a human operator to manipulate the surgical probe 10. Many different configurations of the handle 18 are possible so as to allow the user control over the surgical probe 10. The handle portion 18 includes a control 20 to permit the user to manipulate the length of the energy delivering member 30 as described more fully below. A power cord 22 is provided that provides power for example, from an external power source.

Positioned at the distal end 16 is the energy-delivering member 30. In an embodiment, the energy-delivering member 30 extends from the distal end 16 in a loop configuration as shown in FIG. 1. In this embodiment, the energy-delivering member 30 exits from the distal end 16 of the elongate member 12 at the first port 30 a and loops around and then re-enters the elongate member 12 at the second port 30 b.

Located on the energy-delivering member 30 as shown in FIG. 1 are the energy-delivering elements 32. In one embodiment, the energy-delivering elements 32 include electrodes 40 and a radiofrequency source 42. Electrodes 40 well known to persons skilled in the art, are made of platinum and 10% iridium combination, and other metals are also suitable including platinum alone, gold and stainless steel.

In one embodiment, thermocouples 44 are also provided at the electrodes 40 and may include two thermocouples 44 per electrode 40 to sense the temperature at each electrode 40. Typically, the energy-delivering elements include seven electrodes 40 but the present invention includes probes any number of electrodes 40.

In another embodiment, the radiofrequency source 42 delivers energy in the range of 300 kHz to 2.5 MHz and radiofrequency energy sources that are within the range of about 300 kHz to 1 MHz have also shown to be within the scope of the present invention. Readers should also note that in cases where radio frequency is used the mode for delivering such energy can be either mono-polar or bi-polar. Power levels at approximately 50 Watts with a target temperature of 65° C. measured at the interface of the energy-delivering elements 32 and the tissue under treatment have been shown to yield good tissue shrinkage. Temperature ranges from 50° C. to 80° C. as measured at the interface are within the scope of the present invention with treatment times of approximately 60 seconds. Other types of energy delivering elements such as microwave, ultrasound, laser irradiation, or any other energy source able to provide the proper temperature needed to effect tissue shrinkage on heart structures.

In one embodiment, thermocouples 44—are also provided at the electrodes 40 and may include two thermocouples 44—per electrode 40 to sense the temperature at each electrode 40. Typically, the energy-delivering elements include seven electrodes 40 but the present invention includes probes any number of electrodes 40.

FIG. 3 illustrates an embodiment where additional length of the energy-delivering member 30 has been dispensed out via either first port 30 a or second port 30 b to adjust the position of the energy-delivering elements 32 by use of the control 20. As shown in FIG. 5, this allows for selective placement of the energy-delivering elements 32 on an anatomical structure of the heart or a particular portion of a heart valve for treatment by the energy-delivering elements 32 without the need to withdraw the energy-delivering member 30 from the patient.

FIG. 4 illustrate an embodiment where a portion of the length of the energy-delivering member 30 has been withdrawn in via either first port 30 a or second port 30 b to place the energy-delivering elements 32 at a different location, for example, to treat a different portion of the heart such as for repairing an annular organ structure of a heart valve, an annular organ structure of a venous valve, a valve leaflet, chordae tendinae, papillary muscles, and the like.

FIG. 5 illustrates a further re-positioning of the energy-delivering elements 32 by withdrawing a further length of the energy-delivering member 30 via either first port 30 a or second port 30 b. As shown in both FIG. 4 and FIG. 5, the selected positioning of the energy-delivering elements 32 modifies the loop configuration of the energy-delivering member 30 and allows many targeted areas of the heart to be treated without the need to withdraw the energy-delivering member 30 from the patient.

From the foregoing, a surgical probe and methods for treatment of anatomical structures within the heart have been disclosed. While the invention has been described with reference to specific embodiments, the description herein is illustrative of the invention and is not to be construed as limiting the invention to particular embodiments or features. Numerous modifications and applications may occur to persons skilled in the art without departing from the true spirit and scope of the invention as described by the appended claims including the full breadth and scope of equivalents thereof.

Claims (11)

1. A method for repairing an annular organ structure of a patient using a surgical probe comprising an elongate member having a distal end and a proximal end, an energy-delivering member adjustably extending from the distal end of said elongate member, energy-delivering elements operably connected to said energy-delivering member and a control adjacent to said proximal end, comprising:
placing at least a portion of said energy-delivering member within an annular organ structure of a patient;
placing said energy-delivering elements in communication with selected portions comprising collagen tissue in said annular organ structure by remotely adjust a length of a dispensed portion of said energy-delivering member and a position of energy-delivering elements relative to said dispensed portion by asymmetrically dispensing or withdrawing said energy-delivering member from at least one of a first port and a second port; and
supplying tissue-shrinkable energy to the selected portions of the said annular organ structure in communication with said energy-delivering elements to tighten said selected portions.
2. The method of claim 1 wherein said elongate member is configured to place the energy-delivering elements in communication with the selected portions of the organ structure.
3. The method of claim 1 wherein said energy-delivering elements comprise electrodes.
4. The method of claim 3 further comprising the step of providing at least one thermocouple in communication with each of said electrodes.
5. The method of claim 3 further comprising the step of providing at least two thermocouples in communication with each of said electrodes.
6. The method of claim 1 wherein said energy-delivering elements comprise a source configured to deliver radiofrequency energy in a range of between about 300 kHz to about 2.5 MHz.
7. The method of claim 1 wherein said tissue-shrinkable energy comprises heat energy in a range of between about 50° C. to about 80° C.
8. The method of claim 1 wherein said tissue shrinkable energy comprises radio frequency energy in a range of between about 300 kHz to about 1 MHz.
9. The method of claim 1, wherein said energy-delivering member comprises a first end extending from a first port of said elongate member and a second end extending from a second port of said elongate member.
10. The method of claim 9, further comprising remotely adjusting a position of said energy-delivering elements relative to a dispensed portion of said energy-delivering member without withdrawing said energy-delivering member from a body vessel, wherein said position is adjusted by asymmetrically dispensing or withdrawing said energy-delivering member from at least one of said first port and said second port.
11. The method of claim 1, further comprising the step of remotely adjusting a size of said energy-delivering member to change a dispensed length of said energy-delivering member.
US11537561 2006-09-29 2006-09-29 Surgical probe and methods for targeted treatment of heart structures Expired - Fee Related US8187266B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11537561 US8187266B2 (en) 2006-09-29 2006-09-29 Surgical probe and methods for targeted treatment of heart structures

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11537561 US8187266B2 (en) 2006-09-29 2006-09-29 Surgical probe and methods for targeted treatment of heart structures

Publications (2)

Publication Number Publication Date
US20080082099A1 true US20080082099A1 (en) 2008-04-03
US8187266B2 true US8187266B2 (en) 2012-05-29

Family

ID=39261954

Family Applications (1)

Application Number Title Priority Date Filing Date
US11537561 Expired - Fee Related US8187266B2 (en) 2006-09-29 2006-09-29 Surgical probe and methods for targeted treatment of heart structures

Country Status (1)

Country Link
US (1) US8187266B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9078667B2 (en) 2012-12-11 2015-07-14 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter having reduced force concentration at tissue contact site
US9204888B2 (en) 2007-06-08 2015-12-08 United States Endoscopy Group, Inc. Retrieval device
US9486188B2 (en) 2001-05-18 2016-11-08 United States Endoscopy Group, Inc. Retrieval device
US9572591B2 (en) 2013-09-03 2017-02-21 United States Endoscopy Group, Inc. Endoscopic snare device
US9872700B2 (en) 2013-09-03 2018-01-23 United States Endoscopy Group, Inc. Endoscopic snare device
US9907608B2 (en) 2013-09-05 2018-03-06 Mitragen, Inc. Valve treatment devices, systems, and methods

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005087139A1 (en) * 2004-03-15 2005-09-22 Baker Medical Research Institute Treating valve failure

Citations (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215015A (en) 1979-02-02 1980-07-29 Uop Inc. High octane FCC catalyst
US4238243A (en) 1979-05-29 1980-12-09 Uop Inc. Technique to reduce the zeolite molecular sieve solubility in an aqueous system
US4239615A (en) 1979-12-19 1980-12-16 Uop Inc. High octane FCC process
US4250059A (en) 1979-08-27 1981-02-10 Uop Inc. Catalytic composite, method of manufacture
US4261861A (en) 1979-07-23 1981-04-14 Uop Inc. FCC Catalyst production from used FCC catalyst
US4263174A (en) 1979-08-29 1981-04-21 Uop Inc. Low coke-make FCC catalyst
US4264473A (en) 1980-01-17 1981-04-28 Uop Inc. Method of catalyst manufacture, and catalyst made by said method
US4280897A (en) 1980-05-27 1981-07-28 Uop Inc. Removal of contaminating metals from FCC catalyst by NH4 citrate chelates
US4291186A (en) 1980-03-13 1981-09-22 Uop Inc. Transalkylation process
US4295955A (en) 1980-03-10 1981-10-20 Uop Inc. Attenuation of metal contaminants on cracking catalyst with a boron compound
US4299733A (en) 1980-05-08 1981-11-10 Uop Inc. High octane FCC catalyst
US4300012A (en) 1980-01-17 1981-11-10 Uop Inc. Process for transalkylation of alkylaromatic hydrocarbons
US4299688A (en) 1979-08-29 1981-11-10 Uop Inc. FCC Process using low coke-make FCC catalyst
US4305845A (en) 1980-10-10 1981-12-15 Uop Inc. Zeolitic catalyst
US4312744A (en) 1979-08-29 1982-01-26 Uop Inc. FCC Process using low coke-make FCC catalyst
US4312743A (en) 1979-07-23 1982-01-26 Uop Inc. FCC Process using catalyst produced from used FCC catalyst
US4316819A (en) 1980-08-11 1982-02-23 Uop Inc. Technique to reduce the zeolite molecular sieve solubility in an aqueous system
US4333821A (en) 1980-05-08 1982-06-08 Uop Inc. Process for use of a high octane FCC catalysts
US4337145A (en) 1980-10-10 1982-06-29 Uop Inc. Fluid catalytic cracking process
US4343723A (en) 1980-03-14 1982-08-10 Uop Inc. Catalytic composite from partially crystallized clay
US4345946A (en) 1979-09-14 1982-08-24 Uop Inc. Process for use of a zeolite molecular sieve adsorbent in an aqueous system
US4348272A (en) 1980-07-21 1982-09-07 Uop, Inc. Hydrogen utilization in fluid catalytic cracking
US4364847A (en) 1980-02-25 1982-12-21 Uop Inc. Passivation of metal contaminants on cracking catalyst with a lithium compound
US4493320A (en) * 1982-04-02 1985-01-15 Treat Michael R Bipolar electrocautery surgical snare
US4816339A (en) 1987-04-28 1989-03-28 Baxter International Inc. Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation
US4882113A (en) 1989-01-26 1989-11-21 Baxter International Inc. Heterogeneous elastomeric compositions containing a fluoroelastomer and PTFE and methods for manufacturing said compositions
US4905691A (en) * 1989-04-17 1990-03-06 Everest Medical Corporation Polypectome snare with bipolar electrodes
US5024671A (en) 1988-09-19 1991-06-18 Baxter International Inc. Microporous vascular graft
US5061276A (en) 1987-04-28 1991-10-29 Baxter International Inc. Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation
US5071609A (en) 1986-11-26 1991-12-10 Baxter International Inc. Process of manufacturing porous multi-expanded fluoropolymers
US5318564A (en) * 1992-05-01 1994-06-07 Hemostatic Surgery Corporation Bipolar surgical snare and methods of use
US5376110A (en) 1991-02-14 1994-12-27 Baxter International Inc. Method of manufacturing pliable biological grafts materials
US5549666A (en) 1994-09-02 1996-08-27 Baxter International Inc. Natural tissue valve prostheses having variably complaint leaflets
US5779715A (en) 1997-07-28 1998-07-14 Irvine Biomedical, Inc. Lead extraction system and methods thereof
US5782900A (en) 1997-06-23 1998-07-21 Irvine Biomedical, Inc. Catheter system having safety means
US5792140A (en) 1997-05-15 1998-08-11 Irvine Biomedical, Inc. Catheter having cooled multiple-needle electrode
US5843152A (en) 1997-06-02 1998-12-01 Irvine Biomedical, Inc. Catheter system having a ball electrode
US5843020A (en) 1997-04-16 1998-12-01 Irvine Biomedical, Inc. Ablation device and methods
US5868741A (en) 1997-05-21 1999-02-09 Irvine Biomedical, Inc. Ablation catheter system having fixation tines
US5876399A (en) 1997-05-28 1999-03-02 Irvine Biomedical, Inc. Catheter system and methods thereof
US5876340A (en) 1997-04-17 1999-03-02 Irvine Biomedical, Inc. Ablation apparatus with ultrasonic imaging capabilities
US5891138A (en) 1997-08-11 1999-04-06 Irvine Biomedical, Inc. Catheter system having parallel electrodes
US5891027A (en) 1996-10-21 1999-04-06 Irvine Biomedical, Inc. Cardiovascular catheter system with an inflatable soft tip
US5893884A (en) 1997-05-19 1999-04-13 Irvine Biomedical, Inc. Catheter system having rollable electrode means
US5897554A (en) 1997-03-01 1999-04-27 Irvine Biomedical, Inc. Steerable catheter having a loop electrode
US5913856A (en) 1997-05-19 1999-06-22 Irvine Biomedical, Inc. Catheter system having a porous shaft and fluid irrigation capabilities
US5938658A (en) 1997-12-02 1999-08-17 Tu; Hosheng Device and methods for treating canker sores by RF ablation
US5941845A (en) 1997-08-05 1999-08-24 Irvine Biomedical, Inc. Catheter having multiple-needle electrode and methods thereof
US5948009A (en) 1998-03-06 1999-09-07 Tu; Hosheng Apparatus and methods for medical ablation use
US5951471A (en) 1998-03-09 1999-09-14 Irvine Biomedical, Inc. Catheter-based coronary sinus mapping and ablation
US5954649A (en) 1997-10-20 1999-09-21 Irvine Biomedical, Inc. Catheter system having ultrasound locating capabilities
US5957862A (en) 1997-12-01 1999-09-28 Lu; Cheng-Liang Acupuncture device system and methods thereof
US5968005A (en) 1998-01-07 1999-10-19 Tu; Hosheng Devices and means for treating canker sores
US5971968A (en) 1999-04-08 1999-10-26 Irvine Biomedical, Inc. Catheter probe having contrast media delivery means
US5980563A (en) 1998-08-31 1999-11-09 Tu; Lily Chen Ablation apparatus and methods for treating atherosclerosis
US5980515A (en) 1997-12-19 1999-11-09 Irvine Biomedical, Inc. Devices and methods for lead extraction
US5989248A (en) 1998-04-07 1999-11-23 Tu; Hosheng Medical device and methods for treating tissues
US5997534A (en) 1998-06-08 1999-12-07 Tu; Hosheng Medical ablation device and methods thereof
US6006123A (en) 1997-10-29 1999-12-21 Irvine Biomedical, Inc. Electrode catheter system and methods for using same
US6016437A (en) 1996-10-21 2000-01-18 Irvine Biomedical, Inc. Catheter probe system with inflatable soft shafts
US6017324A (en) 1998-10-20 2000-01-25 Tu; Lily Chen Dilatation catheter having a bifurcated balloon
US6024742A (en) 1998-08-22 2000-02-15 Tu; Lily Chen Ablation apparatus for treating hemorrhoids
US6033402A (en) 1998-09-28 2000-03-07 Irvine Biomedical, Inc. Ablation device for lead extraction and methods thereof
US6033403A (en) 1998-10-08 2000-03-07 Irvine Biomedical, Inc. Long electrode catheter system and methods thereof
US6036689A (en) 1998-09-24 2000-03-14 Tu; Lily Chen Ablation device for treating atherosclerotic tissues
US6050993A (en) 1998-07-27 2000-04-18 Quantum Therapeutics Corp. Medical device and methods for treating hemorrhoids
US6053913A (en) 1998-09-10 2000-04-25 Tu; Lily Chen Rapid exchange stented balloon catheter having ablation capabilities
US6068645A (en) 1999-06-07 2000-05-30 Tu; Hosheng Filter system and methods for removing blood clots and biological material
US6071279A (en) * 1996-12-19 2000-06-06 Ep Technologies, Inc. Branched structures for supporting multiple electrode elements
US6077298A (en) 1999-02-20 2000-06-20 Tu; Lily Chen Expandable/retractable stent and methods thereof
US6090134A (en) 1999-02-16 2000-07-18 Polymerex Medical Corp. Surface fluorinated stent and methods thereof
US6096033A (en) 1998-07-20 2000-08-01 Tu; Hosheng Medical device having ultrasonic ablation capability
US6104952A (en) 1998-01-07 2000-08-15 Tu; Lily Chen Devices for treating canker sores, tissues and methods thereof
US6102908A (en) 1999-01-04 2000-08-15 Tu; Lily Chen Rotatable apparatus having ablation capabilities
US6113593A (en) 1999-02-01 2000-09-05 Tu; Lily Chen Ablation apparatus having temperature and force sensing capabilities
US6123718A (en) 1998-11-02 2000-09-26 Polymerex Medical Corp. Balloon catheter
US6123703A (en) 1998-09-19 2000-09-26 Tu; Lily Chen Ablation catheter and methods for treating tissues
US6129725A (en) 1998-12-04 2000-10-10 Tu; Lily Chen Methods for reduction of restenosis
US6149647A (en) 1999-04-19 2000-11-21 Tu; Lily Chen Apparatus and methods for tissue treatment
US6179789B1 (en) 1999-05-03 2001-01-30 Lily Chen Tu Enhanced radioactive stent for reduction of restenosis
US6206842B1 (en) 1998-08-03 2001-03-27 Lily Chen Tu Ultrasonic operation device
US6217576B1 (en) 1997-05-19 2001-04-17 Irvine Biomedical Inc. Catheter probe for treating focal atrial fibrillation in pulmonary veins
US6221070B1 (en) 1996-10-18 2001-04-24 Irvine Biomedical, Inc. Steerable ablation catheter system having disposable shaft
US6226554B1 (en) 1997-06-02 2001-05-01 Hosheng Tu Catheter system having a ball electrode and methods thereof
US6228109B1 (en) 1998-08-31 2001-05-08 Lily Chen Tu Methods for treating atherosclerosis and vulnerable plaques
US6233477B1 (en) 1997-10-20 2001-05-15 Irvine Biomedical, Inc. Catheter system having controllable ultrasound locating means
US6235024B1 (en) 1999-06-21 2001-05-22 Hosheng Tu Catheters system having dual ablation capability
US6238390B1 (en) 1998-05-27 2001-05-29 Irvine Biomedical, Inc. Ablation catheter system having linear lesion capabilities
US6241726B1 (en) 1997-05-21 2001-06-05 Irvine Biomedical, Inc. Catheter system having a tip section with fixation means
US6241692B1 (en) 1998-10-06 2001-06-05 Irvine Biomedical, Inc. Ultrasonic ablation device and methods for lead extraction
US6241727B1 (en) 1998-05-27 2001-06-05 Irvine Biomedical, Inc. Ablation catheter system having circular lesion capabilities
US6246899B1 (en) 1997-10-20 2001-06-12 Irvine Biomedical, Inc. Ultrasound locating system having ablation capabilities
US6246914B1 (en) 1999-08-12 2001-06-12 Irvine Biomedical, Inc. High torque catheter and methods thereof
US6245067B1 (en) 1997-04-16 2001-06-12 Irvine Biomedical, Inc. Ablation device and methods having perpendicular electrodes
US6259941B1 (en) 1997-10-20 2001-07-10 Irvine Biomedical, Inc. Intravascular ultrasound locating system
US6267781B1 (en) 1998-08-31 2001-07-31 Quantum Therapeutics Corp. Medical device and methods for treating valvular annulus
US6283962B1 (en) 1998-06-08 2001-09-04 Quantum Therapeutics Corp. Device for valvular annulus treatment and methods thereof
US6290697B1 (en) 1998-12-01 2001-09-18 Irvine Biomedical, Inc. Self-guiding catheter system for tissue ablation
US6306133B1 (en) 1999-10-02 2001-10-23 Quantum Cor Incorporated Ablation catheter system and methods for repairing a valvular annulus
US6308090B1 (en) 1998-03-09 2001-10-23 Irvine Biomedical, Inc. Devices and methods for coronary sinus mapping
US6319251B1 (en) 1998-09-24 2001-11-20 Hosheng Tu Medical device and methods for treating intravascular restenosis
US6322583B1 (en) 1998-03-23 2001-11-27 Hosheng Tu Medical device and methods thereof
US6346105B1 (en) 1998-07-27 2002-02-12 Quantum Cor Incorporated Device for treating tissue and methods thereof
US6406493B1 (en) 2000-06-02 2002-06-18 Hosheng Tu Expandable annuloplasty ring and methods of use
US6423023B1 (en) 2000-02-02 2002-07-23 Chang Yu-An Method and apparatus for enhanced plasmapheresis
US6451011B2 (en) 1999-01-19 2002-09-17 Hosheng Tu Medical device having temperature sensing and ablation capabilities
US6485489B2 (en) 1999-10-02 2002-11-26 Quantum Cor, Inc. Catheter system for repairing a mitral valve annulus
US6506398B1 (en) 2000-04-28 2003-01-14 Hosheng Tu Device for treating diabetes and methods thereof
US20030060822A1 (en) * 1998-05-06 2003-03-27 Schaer Alan K. Irrigated ablation device assembly
US6551312B2 (en) 2001-03-09 2003-04-22 Quantum Cor, Inc. Wireless electrosurgical device and methods thereof
US6569163B2 (en) 2001-03-09 2003-05-27 Quantumcor, Inc. Wireless electrosurgical adapter unit and methods thereof
US6575971B2 (en) 2001-11-15 2003-06-10 Quantum Cor, Inc. Cardiac valve leaflet stapler device and methods thereof
US6624138B1 (en) 2001-09-27 2003-09-23 Gp Medical Drug-loaded biological material chemically treated with genipin
US6666841B2 (en) 2001-05-02 2003-12-23 Glaukos Corporation Bifurcatable trabecular shunt for glaucoma treatment
US6682558B2 (en) 2001-05-10 2004-01-27 3F Therapeutics, Inc. Delivery system for a stentless valve bioprosthesis
US6685702B2 (en) 2001-07-06 2004-02-03 Rodolfo C. Quijano Device for treating tissue and methods thereof
US6736791B1 (en) 2000-04-14 2004-05-18 Glaukos Corporation Glaucoma treatment device
US6807444B2 (en) 2001-11-05 2004-10-19 Hosheng Tu Apparatus and methods for monitoring tissue impedance
US6805711B2 (en) 2000-06-02 2004-10-19 3F Therapeutics, Inc. Expandable medical implant and percutaneous delivery
US6830585B1 (en) 2003-01-14 2004-12-14 3F Therapeutics, Inc. Percutaneously deliverable heart valve and methods of implantation
US6830586B2 (en) 2002-02-28 2004-12-14 3F Therapeutics, Inc. Stentless atrioventricular heart valve fabricated from a singular flat membrane
US6832111B2 (en) 2001-07-06 2004-12-14 Hosheng Tu Device for tumor diagnosis and methods thereof
US6875231B2 (en) 2002-09-11 2005-04-05 3F Therapeutics, Inc. Percutaneously deliverable heart valve
US6939359B2 (en) 2001-05-21 2005-09-06 3F Therapeutics, Inc. Apparatus and methods for valve removal
US6949518B1 (en) 2003-06-25 2005-09-27 Pao-Hsien Chu Methods for treating macular degeneration with topiramate
US20050240249A1 (en) 2003-10-28 2005-10-27 Hosheng Tu Methods for treating mitral valve annulus with biodegradable compression element
US6960178B2 (en) 2000-02-02 2005-11-01 Xepmed, Inc. Apparatus for enhanced plasmapheresis and methods thereof
US6964661B2 (en) * 2003-04-02 2005-11-15 Boston Scientific Scimed, Inc. Endovenous ablation mechanism with feedback control
US6969367B2 (en) 2000-02-02 2005-11-29 Xepmed, Inc. Extracorporeal pathogen reduction system
US6974464B2 (en) 2002-02-28 2005-12-13 3F Therapeutics, Inc. Supportless atrioventricular heart valve and minimally invasive delivery systems thereof
US6981958B1 (en) 2001-05-02 2006-01-03 Glaukos Corporation Implant with pressure sensor for glaucoma treatment
US6998418B1 (en) 1996-11-05 2006-02-14 Gp Medical, Inc. Acellular biological material chemically treated with genipin
US7004911B1 (en) 2003-02-24 2006-02-28 Hosheng Tu Optical thermal mapping for detecting vulnerable plaque
US7029675B1 (en) 2003-06-04 2006-04-18 Shu-Wha Lin Hepsin antagonist and methods of use
US7041132B2 (en) 2002-08-16 2006-05-09 3F Therapeutics, Inc, Percutaneously delivered heart valve and delivery means thereof
US7052495B2 (en) * 1999-08-06 2006-05-30 Scimed Life Systems, Inc. Polypectomy snare instrument
US7060684B1 (en) 2002-12-16 2006-06-13 Quijano Rodolfo C Device for treating diabetes and methods thereof
US7094225B2 (en) 2001-05-03 2006-08-22 Glaukos Corporation Medical device and methods of use of glaucoma treatment
US7101857B2 (en) 1996-11-05 2006-09-05 Gp Medical, Inc. Crosslinkable biological material and medical uses
US7135009B2 (en) 2001-04-07 2006-11-14 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
US7153299B1 (en) 2003-02-24 2006-12-26 Maxwell Sensors Inc. Optical apparatus for detecting and treating vulnerable plaque
US7163543B2 (en) 2001-11-08 2007-01-16 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
US7175619B2 (en) * 1994-10-07 2007-02-13 Boston Scientific Scimed, Inc. Loop structures for positioning a diagnostic or therapeutic element on the epicardium or other organ surface
US7186232B1 (en) 2002-03-07 2007-03-06 Glaukoa Corporation Fluid infusion methods for glaucoma treatment
US7229469B1 (en) 1999-10-02 2007-06-12 Quantumcor, Inc. Methods for treating and repairing mitral valve annulus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792900A (en) * 1991-10-21 1998-08-11 The Trustees Of The University Of Pennsylvania Compositions and methods for producing and using homogenous neuronal cell transplants
US5612066A (en) * 1995-04-11 1997-03-18 Davidson Textron, Inc. Heat insulating mold panel for a mold tool
US5867741A (en) * 1996-10-31 1999-02-02 Olympus Optical Co., Ltd. Camera for image pickup on film and also for electronic image-sensing
US6248390B1 (en) * 2000-02-22 2001-06-19 Suzanne Jaffe Stillman Fiber-water—water containing soluble fiber
US6926745B2 (en) * 2002-05-17 2005-08-09 The Clorox Company Hydroscopic polymer gel films for easier cleaning

Patent Citations (155)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215015A (en) 1979-02-02 1980-07-29 Uop Inc. High octane FCC catalyst
US4238243A (en) 1979-05-29 1980-12-09 Uop Inc. Technique to reduce the zeolite molecular sieve solubility in an aqueous system
US4261861A (en) 1979-07-23 1981-04-14 Uop Inc. FCC Catalyst production from used FCC catalyst
US4312743A (en) 1979-07-23 1982-01-26 Uop Inc. FCC Process using catalyst produced from used FCC catalyst
US4250059A (en) 1979-08-27 1981-02-10 Uop Inc. Catalytic composite, method of manufacture
US4299688A (en) 1979-08-29 1981-11-10 Uop Inc. FCC Process using low coke-make FCC catalyst
US4263174A (en) 1979-08-29 1981-04-21 Uop Inc. Low coke-make FCC catalyst
US4312744A (en) 1979-08-29 1982-01-26 Uop Inc. FCC Process using low coke-make FCC catalyst
US4345946A (en) 1979-09-14 1982-08-24 Uop Inc. Process for use of a zeolite molecular sieve adsorbent in an aqueous system
US4239615A (en) 1979-12-19 1980-12-16 Uop Inc. High octane FCC process
US4264473A (en) 1980-01-17 1981-04-28 Uop Inc. Method of catalyst manufacture, and catalyst made by said method
US4300012A (en) 1980-01-17 1981-11-10 Uop Inc. Process for transalkylation of alkylaromatic hydrocarbons
US4364847A (en) 1980-02-25 1982-12-21 Uop Inc. Passivation of metal contaminants on cracking catalyst with a lithium compound
US4295955A (en) 1980-03-10 1981-10-20 Uop Inc. Attenuation of metal contaminants on cracking catalyst with a boron compound
US4291186A (en) 1980-03-13 1981-09-22 Uop Inc. Transalkylation process
US4343723A (en) 1980-03-14 1982-08-10 Uop Inc. Catalytic composite from partially crystallized clay
US4299733A (en) 1980-05-08 1981-11-10 Uop Inc. High octane FCC catalyst
US4333821A (en) 1980-05-08 1982-06-08 Uop Inc. Process for use of a high octane FCC catalysts
US4280897A (en) 1980-05-27 1981-07-28 Uop Inc. Removal of contaminating metals from FCC catalyst by NH4 citrate chelates
US4348272A (en) 1980-07-21 1982-09-07 Uop, Inc. Hydrogen utilization in fluid catalytic cracking
US4316819A (en) 1980-08-11 1982-02-23 Uop Inc. Technique to reduce the zeolite molecular sieve solubility in an aqueous system
US4305845A (en) 1980-10-10 1981-12-15 Uop Inc. Zeolitic catalyst
US4337145A (en) 1980-10-10 1982-06-29 Uop Inc. Fluid catalytic cracking process
US4493320A (en) * 1982-04-02 1985-01-15 Treat Michael R Bipolar electrocautery surgical snare
US5071609A (en) 1986-11-26 1991-12-10 Baxter International Inc. Process of manufacturing porous multi-expanded fluoropolymers
US4816339A (en) 1987-04-28 1989-03-28 Baxter International Inc. Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation
US5061276A (en) 1987-04-28 1991-10-29 Baxter International Inc. Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation
US5024671A (en) 1988-09-19 1991-06-18 Baxter International Inc. Microporous vascular graft
US4882113A (en) 1989-01-26 1989-11-21 Baxter International Inc. Heterogeneous elastomeric compositions containing a fluoroelastomer and PTFE and methods for manufacturing said compositions
US4905691A (en) * 1989-04-17 1990-03-06 Everest Medical Corporation Polypectome snare with bipolar electrodes
US5376110A (en) 1991-02-14 1994-12-27 Baxter International Inc. Method of manufacturing pliable biological grafts materials
US5318564A (en) * 1992-05-01 1994-06-07 Hemostatic Surgery Corporation Bipolar surgical snare and methods of use
US5549666A (en) 1994-09-02 1996-08-27 Baxter International Inc. Natural tissue valve prostheses having variably complaint leaflets
US5769780A (en) 1994-09-02 1998-06-23 Baxter International Inc. Method of manufacturing natural tissue valves having variably compliant leaflets
US7175619B2 (en) * 1994-10-07 2007-02-13 Boston Scientific Scimed, Inc. Loop structures for positioning a diagnostic or therapeutic element on the epicardium or other organ surface
US6221070B1 (en) 1996-10-18 2001-04-24 Irvine Biomedical, Inc. Steerable ablation catheter system having disposable shaft
US6016437A (en) 1996-10-21 2000-01-18 Irvine Biomedical, Inc. Catheter probe system with inflatable soft shafts
US5891027A (en) 1996-10-21 1999-04-06 Irvine Biomedical, Inc. Cardiovascular catheter system with an inflatable soft tip
US6998418B1 (en) 1996-11-05 2006-02-14 Gp Medical, Inc. Acellular biological material chemically treated with genipin
US7101857B2 (en) 1996-11-05 2006-09-05 Gp Medical, Inc. Crosslinkable biological material and medical uses
US6071279A (en) * 1996-12-19 2000-06-06 Ep Technologies, Inc. Branched structures for supporting multiple electrode elements
US5897554A (en) 1997-03-01 1999-04-27 Irvine Biomedical, Inc. Steerable catheter having a loop electrode
US5843020A (en) 1997-04-16 1998-12-01 Irvine Biomedical, Inc. Ablation device and methods
US6245067B1 (en) 1997-04-16 2001-06-12 Irvine Biomedical, Inc. Ablation device and methods having perpendicular electrodes
US5876340A (en) 1997-04-17 1999-03-02 Irvine Biomedical, Inc. Ablation apparatus with ultrasonic imaging capabilities
US5792140A (en) 1997-05-15 1998-08-11 Irvine Biomedical, Inc. Catheter having cooled multiple-needle electrode
US6156033A (en) 1997-05-15 2000-12-05 Tu; Hosheng Ablation catheter having electrode means and methods thereof
US5938659A (en) 1997-05-15 1999-08-17 Irvine Biomedical, Inc. Catheter system having cooled multiple-needle electrode and methods thereof
US6231570B1 (en) 1997-05-15 2001-05-15 Hosheng Tu Electrode catheter system for tissue ablation
US5913856A (en) 1997-05-19 1999-06-22 Irvine Biomedical, Inc. Catheter system having a porous shaft and fluid irrigation capabilities
US6217576B1 (en) 1997-05-19 2001-04-17 Irvine Biomedical Inc. Catheter probe for treating focal atrial fibrillation in pulmonary veins
US5893884A (en) 1997-05-19 1999-04-13 Irvine Biomedical, Inc. Catheter system having rollable electrode means
US5868741A (en) 1997-05-21 1999-02-09 Irvine Biomedical, Inc. Ablation catheter system having fixation tines
US6241726B1 (en) 1997-05-21 2001-06-05 Irvine Biomedical, Inc. Catheter system having a tip section with fixation means
US5891137A (en) 1997-05-21 1999-04-06 Irvine Biomedical, Inc. Catheter system having a tip with fixation means
US5876399A (en) 1997-05-28 1999-03-02 Irvine Biomedical, Inc. Catheter system and methods thereof
US5843152A (en) 1997-06-02 1998-12-01 Irvine Biomedical, Inc. Catheter system having a ball electrode
US6226554B1 (en) 1997-06-02 2001-05-01 Hosheng Tu Catheter system having a ball electrode and methods thereof
US5782900A (en) 1997-06-23 1998-07-21 Irvine Biomedical, Inc. Catheter system having safety means
US5992418A (en) 1997-06-23 1999-11-30 Irvine Biomedical , Inc. Catheter system having safety means and methods thereof
US6001095A (en) 1997-06-23 1999-12-14 Irvine Biomedical, Inc. Catheter system having closely spaced distal bipolar electrodes
US5779715A (en) 1997-07-28 1998-07-14 Irvine Biomedical, Inc. Lead extraction system and methods thereof
US5941845A (en) 1997-08-05 1999-08-24 Irvine Biomedical, Inc. Catheter having multiple-needle electrode and methods thereof
US5891138A (en) 1997-08-11 1999-04-06 Irvine Biomedical, Inc. Catheter system having parallel electrodes
US6246899B1 (en) 1997-10-20 2001-06-12 Irvine Biomedical, Inc. Ultrasound locating system having ablation capabilities
US5954649A (en) 1997-10-20 1999-09-21 Irvine Biomedical, Inc. Catheter system having ultrasound locating capabilities
US6233477B1 (en) 1997-10-20 2001-05-15 Irvine Biomedical, Inc. Catheter system having controllable ultrasound locating means
US6259941B1 (en) 1997-10-20 2001-07-10 Irvine Biomedical, Inc. Intravascular ultrasound locating system
US6006123A (en) 1997-10-29 1999-12-21 Irvine Biomedical, Inc. Electrode catheter system and methods for using same
US5957862A (en) 1997-12-01 1999-09-28 Lu; Cheng-Liang Acupuncture device system and methods thereof
US5938658A (en) 1997-12-02 1999-08-17 Tu; Hosheng Device and methods for treating canker sores by RF ablation
US6161548A (en) 1997-12-02 2000-12-19 Tu; Hosheng Ablation device and methods thereof
US5980515A (en) 1997-12-19 1999-11-09 Irvine Biomedical, Inc. Devices and methods for lead extraction
US5968005A (en) 1998-01-07 1999-10-19 Tu; Hosheng Devices and means for treating canker sores
US6104952A (en) 1998-01-07 2000-08-15 Tu; Lily Chen Devices for treating canker sores, tissues and methods thereof
US5948009A (en) 1998-03-06 1999-09-07 Tu; Hosheng Apparatus and methods for medical ablation use
US6165206A (en) 1998-03-06 2000-12-26 Tu; Hosheng Apparatus for medical ablation use and methods thereof
US6308090B1 (en) 1998-03-09 2001-10-23 Irvine Biomedical, Inc. Devices and methods for coronary sinus mapping
US5951471A (en) 1998-03-09 1999-09-14 Irvine Biomedical, Inc. Catheter-based coronary sinus mapping and ablation
US6322583B1 (en) 1998-03-23 2001-11-27 Hosheng Tu Medical device and methods thereof
US5989248A (en) 1998-04-07 1999-11-23 Tu; Hosheng Medical device and methods for treating tissues
US20030060822A1 (en) * 1998-05-06 2003-03-27 Schaer Alan K. Irrigated ablation device assembly
US6241727B1 (en) 1998-05-27 2001-06-05 Irvine Biomedical, Inc. Ablation catheter system having circular lesion capabilities
US6238390B1 (en) 1998-05-27 2001-05-29 Irvine Biomedical, Inc. Ablation catheter system having linear lesion capabilities
US6283962B1 (en) 1998-06-08 2001-09-04 Quantum Therapeutics Corp. Device for valvular annulus treatment and methods thereof
US5997534A (en) 1998-06-08 1999-12-07 Tu; Hosheng Medical ablation device and methods thereof
US6096033A (en) 1998-07-20 2000-08-01 Tu; Hosheng Medical device having ultrasonic ablation capability
US6346105B1 (en) 1998-07-27 2002-02-12 Quantum Cor Incorporated Device for treating tissue and methods thereof
US6050993A (en) 1998-07-27 2000-04-18 Quantum Therapeutics Corp. Medical device and methods for treating hemorrhoids
US6206842B1 (en) 1998-08-03 2001-03-27 Lily Chen Tu Ultrasonic operation device
US6024742A (en) 1998-08-22 2000-02-15 Tu; Lily Chen Ablation apparatus for treating hemorrhoids
US6267781B1 (en) 1998-08-31 2001-07-31 Quantum Therapeutics Corp. Medical device and methods for treating valvular annulus
US5980563A (en) 1998-08-31 1999-11-09 Tu; Lily Chen Ablation apparatus and methods for treating atherosclerosis
US6228109B1 (en) 1998-08-31 2001-05-08 Lily Chen Tu Methods for treating atherosclerosis and vulnerable plaques
US6053913A (en) 1998-09-10 2000-04-25 Tu; Lily Chen Rapid exchange stented balloon catheter having ablation capabilities
US6123703A (en) 1998-09-19 2000-09-26 Tu; Lily Chen Ablation catheter and methods for treating tissues
US6319251B1 (en) 1998-09-24 2001-11-20 Hosheng Tu Medical device and methods for treating intravascular restenosis
US6036689A (en) 1998-09-24 2000-03-14 Tu; Lily Chen Ablation device for treating atherosclerotic tissues
US6033402A (en) 1998-09-28 2000-03-07 Irvine Biomedical, Inc. Ablation device for lead extraction and methods thereof
US6241692B1 (en) 1998-10-06 2001-06-05 Irvine Biomedical, Inc. Ultrasonic ablation device and methods for lead extraction
US6033403A (en) 1998-10-08 2000-03-07 Irvine Biomedical, Inc. Long electrode catheter system and methods thereof
US6017324A (en) 1998-10-20 2000-01-25 Tu; Lily Chen Dilatation catheter having a bifurcated balloon
US6123718A (en) 1998-11-02 2000-09-26 Polymerex Medical Corp. Balloon catheter
US6290697B1 (en) 1998-12-01 2001-09-18 Irvine Biomedical, Inc. Self-guiding catheter system for tissue ablation
US6129725A (en) 1998-12-04 2000-10-10 Tu; Lily Chen Methods for reduction of restenosis
US6102908A (en) 1999-01-04 2000-08-15 Tu; Lily Chen Rotatable apparatus having ablation capabilities
US6451011B2 (en) 1999-01-19 2002-09-17 Hosheng Tu Medical device having temperature sensing and ablation capabilities
US6113593A (en) 1999-02-01 2000-09-05 Tu; Lily Chen Ablation apparatus having temperature and force sensing capabilities
US6090134A (en) 1999-02-16 2000-07-18 Polymerex Medical Corp. Surface fluorinated stent and methods thereof
US6077298A (en) 1999-02-20 2000-06-20 Tu; Lily Chen Expandable/retractable stent and methods thereof
US5971968A (en) 1999-04-08 1999-10-26 Irvine Biomedical, Inc. Catheter probe having contrast media delivery means
US6149647A (en) 1999-04-19 2000-11-21 Tu; Lily Chen Apparatus and methods for tissue treatment
US6179789B1 (en) 1999-05-03 2001-01-30 Lily Chen Tu Enhanced radioactive stent for reduction of restenosis
US6068645A (en) 1999-06-07 2000-05-30 Tu; Hosheng Filter system and methods for removing blood clots and biological material
US6235024B1 (en) 1999-06-21 2001-05-22 Hosheng Tu Catheters system having dual ablation capability
US7052495B2 (en) * 1999-08-06 2006-05-30 Scimed Life Systems, Inc. Polypectomy snare instrument
US6246914B1 (en) 1999-08-12 2001-06-12 Irvine Biomedical, Inc. High torque catheter and methods thereof
US7229469B1 (en) 1999-10-02 2007-06-12 Quantumcor, Inc. Methods for treating and repairing mitral valve annulus
US6306133B1 (en) 1999-10-02 2001-10-23 Quantum Cor Incorporated Ablation catheter system and methods for repairing a valvular annulus
US6485489B2 (en) 1999-10-02 2002-11-26 Quantum Cor, Inc. Catheter system for repairing a mitral valve annulus
US6423023B1 (en) 2000-02-02 2002-07-23 Chang Yu-An Method and apparatus for enhanced plasmapheresis
US6969367B2 (en) 2000-02-02 2005-11-29 Xepmed, Inc. Extracorporeal pathogen reduction system
US6960178B2 (en) 2000-02-02 2005-11-01 Xepmed, Inc. Apparatus for enhanced plasmapheresis and methods thereof
US6736791B1 (en) 2000-04-14 2004-05-18 Glaukos Corporation Glaucoma treatment device
US6506398B1 (en) 2000-04-28 2003-01-14 Hosheng Tu Device for treating diabetes and methods thereof
US6805711B2 (en) 2000-06-02 2004-10-19 3F Therapeutics, Inc. Expandable medical implant and percutaneous delivery
US6406493B1 (en) 2000-06-02 2002-06-18 Hosheng Tu Expandable annuloplasty ring and methods of use
US6551312B2 (en) 2001-03-09 2003-04-22 Quantum Cor, Inc. Wireless electrosurgical device and methods thereof
US6569163B2 (en) 2001-03-09 2003-05-27 Quantumcor, Inc. Wireless electrosurgical adapter unit and methods thereof
US7135009B2 (en) 2001-04-07 2006-11-14 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
US6981958B1 (en) 2001-05-02 2006-01-03 Glaukos Corporation Implant with pressure sensor for glaucoma treatment
US6666841B2 (en) 2001-05-02 2003-12-23 Glaukos Corporation Bifurcatable trabecular shunt for glaucoma treatment
US7094225B2 (en) 2001-05-03 2006-08-22 Glaukos Corporation Medical device and methods of use of glaucoma treatment
US6682558B2 (en) 2001-05-10 2004-01-27 3F Therapeutics, Inc. Delivery system for a stentless valve bioprosthesis
US6939359B2 (en) 2001-05-21 2005-09-06 3F Therapeutics, Inc. Apparatus and methods for valve removal
US6832111B2 (en) 2001-07-06 2004-12-14 Hosheng Tu Device for tumor diagnosis and methods thereof
US6685702B2 (en) 2001-07-06 2004-02-03 Rodolfo C. Quijano Device for treating tissue and methods thereof
US6624138B1 (en) 2001-09-27 2003-09-23 Gp Medical Drug-loaded biological material chemically treated with genipin
US6807444B2 (en) 2001-11-05 2004-10-19 Hosheng Tu Apparatus and methods for monitoring tissue impedance
US7163543B2 (en) 2001-11-08 2007-01-16 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
US6926715B1 (en) 2001-11-15 2005-08-09 Wallace Neil Hauck Cardiac valve leaflet attachment device and methods thereof
US6575971B2 (en) 2001-11-15 2003-06-10 Quantum Cor, Inc. Cardiac valve leaflet stapler device and methods thereof
US6974464B2 (en) 2002-02-28 2005-12-13 3F Therapeutics, Inc. Supportless atrioventricular heart valve and minimally invasive delivery systems thereof
US6830586B2 (en) 2002-02-28 2004-12-14 3F Therapeutics, Inc. Stentless atrioventricular heart valve fabricated from a singular flat membrane
US7186232B1 (en) 2002-03-07 2007-03-06 Glaukoa Corporation Fluid infusion methods for glaucoma treatment
US7041132B2 (en) 2002-08-16 2006-05-09 3F Therapeutics, Inc, Percutaneously delivered heart valve and delivery means thereof
US6875231B2 (en) 2002-09-11 2005-04-05 3F Therapeutics, Inc. Percutaneously deliverable heart valve
US7060684B1 (en) 2002-12-16 2006-06-13 Quijano Rodolfo C Device for treating diabetes and methods thereof
US6830585B1 (en) 2003-01-14 2004-12-14 3F Therapeutics, Inc. Percutaneously deliverable heart valve and methods of implantation
US7004911B1 (en) 2003-02-24 2006-02-28 Hosheng Tu Optical thermal mapping for detecting vulnerable plaque
US7153299B1 (en) 2003-02-24 2006-12-26 Maxwell Sensors Inc. Optical apparatus for detecting and treating vulnerable plaque
US6964661B2 (en) * 2003-04-02 2005-11-15 Boston Scientific Scimed, Inc. Endovenous ablation mechanism with feedback control
US7029675B1 (en) 2003-06-04 2006-04-18 Shu-Wha Lin Hepsin antagonist and methods of use
US6949518B1 (en) 2003-06-25 2005-09-27 Pao-Hsien Chu Methods for treating macular degeneration with topiramate
US20050240249A1 (en) 2003-10-28 2005-10-27 Hosheng Tu Methods for treating mitral valve annulus with biodegradable compression element

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486188B2 (en) 2001-05-18 2016-11-08 United States Endoscopy Group, Inc. Retrieval device
US9730716B2 (en) 2001-05-18 2017-08-15 United States Endoscopy Group, Inc. Retrieval device
US9204888B2 (en) 2007-06-08 2015-12-08 United States Endoscopy Group, Inc. Retrieval device
US9826997B2 (en) 2007-06-08 2017-11-28 U.S. Endoscopy Group, Inc. Retrieval device
US9078667B2 (en) 2012-12-11 2015-07-14 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter having reduced force concentration at tissue contact site
US9572591B2 (en) 2013-09-03 2017-02-21 United States Endoscopy Group, Inc. Endoscopic snare device
US9872700B2 (en) 2013-09-03 2018-01-23 United States Endoscopy Group, Inc. Endoscopic snare device
US9907608B2 (en) 2013-09-05 2018-03-06 Mitragen, Inc. Valve treatment devices, systems, and methods
US9987082B2 (en) 2013-09-05 2018-06-05 Mitragen, Inc. Valve treatment devices, systems, and methods

Also Published As

Publication number Publication date Type
US20080082099A1 (en) 2008-04-03 application

Similar Documents

Publication Publication Date Title
David et al. Mitral valve annuloplasty: the effect of the type on left ventricular function
US6004316A (en) Method for the treatment of patent ductus arteriosus
US6546934B1 (en) Noninvasive devices and methods for shrinking of tissues
Carpentier et al. Carpentier's Reconstructive Valve Surgery E-Book
US6572612B2 (en) Ablation catheter and method for isolating a pulmonary vein
US6849075B2 (en) Cardiac ablation devices and methods
US6014589A (en) Catheter having expandable electrodes and adjustable stent
US6837885B2 (en) Surgical probe for supporting inflatable therapeutic devices in contact with tissue in or around body orifices and within tumors
US7373207B2 (en) Treatments for a patient with congestive heart failure
US7241257B1 (en) Devices and methods to perform minimally invasive surgeries
US20060241745A1 (en) Blood flow controlling apparatus
US20030120340A1 (en) Mitral and tricuspid valve repair
US7628789B2 (en) Selective lung tissue ablation
US6626899B2 (en) Apparatus and methods for treating tissue
US7004942B2 (en) Ribbed electrodes and methods for their use
Saltman et al. A completely endoscopic approach to microwave ablation for atrial fibrillation
US7226448B2 (en) Cardiac treatment devices and methods
US20030060813A1 (en) Devices and methods for safely shrinking tissues surrounding a duct, hollow organ or body cavity
US20060015165A1 (en) Conduction block verification probe and method of use
US6893394B2 (en) Illuminated and vacuum assisted retractor
L. COX Cardiac surgery for arrhythmias
US8845717B2 (en) Coaptation enhancement implant, system, and method
US6763836B2 (en) Methods for electrosurgical tendon vascularization
US6805130B2 (en) Methods for electrosurgical tendon vascularization
US20080009843A1 (en) Surgical ablation system with chest wall platform

Legal Events

Date Code Title Description
AS Assignment

Owner name: QUANTUMCOR, INC.,, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DICKENS, DUANE;WITZEL, THOMAS;REEL/FRAME:019251/0971

Effective date: 20070430

AS Assignment

Owner name: VALVECURE, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:QUANTUMCOR, INC.;REEL/FRAME:032308/0860

Effective date: 20140122

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Expired due to failure to pay maintenance fee

Effective date: 20160529